T. Motomiya

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)

K. Simon, T. Hassanein, A. Tran, 2019, Hepatology.

Anticarcinogenic compounds in the Uzbek medicinal plant, Helichrysum maracandicum

H. Nishino, H. Tokuda, Michiho Ito, 2008, Journal of Natural Medicines.

Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial

K. Nakagome, T. Sonoyama, Masaki Kato, 2023, Psychiatry and clinical neurosciences.

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

N. Afdhal, T. Kano, A. Duggal, 2017 .